The Globe and Mail reports in its Tuesday edition that TD Cowen analyst Michael Tupholme continues to rank Stantec "buy." The Globe's David Leeder writes in the Eye On Equities column that Mr. Tupholme's share target advanced by $7 to $183. Analysts on average target the shares at $164.64. Mr. Tupholme predicts accelerated organic growth for most Canadian engineering and construction companies in the third quarter, supported by strong backlogs and favourable demand trends in key end markets. Mr. Tupholme says in a note: "Overall, we remain constructive on the outlook for our covered E&C names, supported by robust backlogs and what we see as continued healthy activity within key end-markets (infrastructure, water, power, defence and mission-critical facilities). Our Q3/25 forecast calls for a pick-up in y/y engineering/construction organic revenue growth at four of five names vs. H1/25. While we do not expect it to weigh meaningfully on performance, the engineering names are likely to see less U.S. emergency response activity vs. the prior year. ... We see ongoing momentum in nuclear, additional Canadian nation-building project developments and possible M&A as potential positive catalysts for the group."